Jazz Pharmaceuticals plc JAZZ

NAS: JAZZ | ISIN: IE00B4Q5ZN47   13/03/2026
178,55 USD (-0,98%)
(-0,98%)   13/03/2026
Grafiek Jazz Pharmaceuticals plc Grafiek Jazz Pharmaceuticals plc

Jazz Pharmaceuticals plc in het nieuws

24 februari 2026 · Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2025 Financial Results and Provides 2026 Financial Guidance · Persbericht

17 februari 2026 · Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences · Persbericht

10 februari 2026 · Jazz Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Tuesday, February 24, 2026 · Persbericht

8 januari 2026 · Jazz Pharmaceuticals Appoints Thomas Riga as Chief Business Officer · Persbericht

6 januari 2026 · Ziihera® (zanidatamab-hrii) Combinations Achieve Unprecedented Results in First-Line HER2+ Locally Advanced or Metastatic GEA Including More Than Two Years Median Overall Survival Benefit · Persbericht

17 december 2025 · Jazz Pharmaceuticals to Participate in Upcoming Investor Events · Persbericht

5 december 2025 · Jazz Pharmaceuticals to Present Extensive New Data and Real-World Evidence Highlighting Epidiolex® (cannabidiol) Outcomes in Treatment-Resistant Epilepsies at the American Epilepsy Society 2025 Annual Meeting · Persbericht

2 december 2025 · Jazz Pharmaceuticals to Present Pivotal Phase 3 Results of Ziihera® (zanidatamab-hrii) Combinations in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma at the 2026 ASCO Gastrointestinal Cancers Symposium · Persbericht

18 november 2025 · Jazz Pharmaceuticals to Participate in Citi's 2025 Global Healthcare Conference · Persbericht

17 november 2025 · Positive HERIZON-GEA-01 Phase 3 Results Support Ziihera® (zanidatamab-hrii) as HER2-Targeted Agent-of-Choice and Ziihera Combination Regimens as New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma · Persbericht

Profiel Jazz Pharmaceuticals plc

Fabricage van farmaceutische preparaten
Farmaceutische producten: Andere
Gezondheidstechnologie
Productie

Mijn selecties